UK Bans Over-the-Counter Sales of Codeine Cough Syrup Amid Addiction Concerns

The decision, made by the Medicines and Healthcare products Regulatory Agency, requires a prescription for codeine linctus to combat rising addiction and misuse.

The UK has banned the sale of codeine cough syrup over-the-counter due to rising concerns of addiction and abuse.
Codeine linctus, an opioid used to treat dry coughs, will now require a prescription following a decision by the Medicines and Healthcare products Regulatory Agency (MHRA).
Pharmacists report aggression from customers addicted to codeine, prompting many to stop stocking the drug.
Alternatives for treating dry coughs, such as cough suppressants and honey and lemon mixes, are recommended by health officials.
The reclassification aims to prioritize patient safety and reduce the risk of addiction and misuse associated with codeine linctus.